Nexgel, Inc. (NXGL) Research & Development (2021 - 2025)

Nexgel's (NXGL) quarterly Research & Development came in at -$6000.0 in Q4 2025, down 185.71% on a QoQ basis from $7000.0 in Q3 2025.

Nexgel, Inc. (NXGL) Research & Development (2021 - 2025) Analysis & Trends

Nexgel (NXGL) has 5 years of Research & Development data on file, last reported at -$6000.0 in Q4 2025.

Quarterly Research & Development changed N/A year-over-year to -$6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (down 97.44% YoY) and the FY2025 annual result came in at $2000.0, down 97.44% from the prior year.
Research & Development retreated to -$6000.0 in Q4 2025, from $7000.0 in the prior quarter.
In the past five years, Research & Development ranged from a high of $193000.0 in Q3 2022 to a low of -$6000.0 in Q4 2025.
A 5-year average of $36312.5 and a median of $13500.0 in 2021 frame the typical range for Research & Development.
Annual changes were most pronounced in 2022 — Research & Development jumped 1010.0% — and 2023, when it sank 96.89%.
Tracing NXGL's Research & Development over 5 years: stood at $14000.0 in 2021, then surged by 178.57% to $39000.0 in 2022, then slumped by 66.67% to $13000.0 in 2023, then jumped by 484.62% to $76000.0 in 2024, then sank by 107.89% to -$6000.0 in 2025.
The last three Research & Development figures came in at -$6000.0 (Q4 2025), $7000.0 (Q3 2025), and $1000.0 (Q1 2025), per Business Quant data.

Download Data